Libbey Inc. (LBY) Has Broken Out To An 8-Month High
Libbey Inc. (LBY) gapped up at the open Monday and has risen steadily in early trade. The stock is now up 0.89 at $8.62.
Source: RTTNews
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis




